Related Experiment Videos
Diabetes in deprived patients
Aurélie Bérot1, Thi-Lan Huong Do2, Hélène Bihan3
1Service de Pédiatrie, CHU Reims, 47 Rue Cognac Jay, 51092 Reims, American Memorial Hospital, France; Laboratoire Éducation et Promotion de la Santé (LEPS), UR 3412, Sorbonne Paris Nord University, F-93430 Villetaneuse, France.
Annales D'Endocrinologie
|July 20, 2026
Summary
Socioeconomic status significantly impacts type-2 diabetes (T2D) risk and outcomes, with disadvantaged individuals facing poorer health behaviors and higher mortality. Healthcare must address these disparities for equitable diabetes care.
Area of Science:
- Endocrinology
- Public Health
- Health Disparities
Background:
- Socioeconomic status (SES) is a critical determinant of health, influencing chronic disease development and management.
- Disadvantaged populations exhibit increased risks for type-2 diabetes (T2D) and poorer health outcomes compared to higher SES groups.
- While T2D shows a socioeconomic gradient, type-1 diabetes (T1D) management and outcomes are also affected by deprivation.
Purpose of the Study:
- To examine the influence of socioeconomic deprivation on T2D and T1D.
- To highlight the association between deprivation, health behaviors, treatment adherence, and glycemic control (HbA1c).
- To emphasize the need for equitable access to diabetes technologies and patient support.
Main Methods:
- Review of existing literature on socioeconomic factors and diabetes.
- Analysis of associations between deprivation, health behaviors, follow-up compliance, and HbA1c levels.
- Consideration of gender-specific disparities in diabetes outcomes.
Main Results:
- Low educational level and disadvantaged area living increase T2D risk by 20-50%.
- Socioeconomic deprivation correlates with poorer health behaviors, lower follow-up compliance, and higher HbA1c in T2D patients, especially women.
- Deprivation also elevates complication and mortality risks in T1D patients.
Conclusions:
- Socioeconomic factors significantly worsen T2D and T1D outcomes, necessitating targeted interventions.
- Healthcare teams must screen for deprivation and assess health literacy to ensure equitable access to care and technologies.
- Collaboration with social workers and health mediators is crucial for patient partnership and improved diabetes management.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...